HIGHLIGHTS
- who: Rui Li from the School of Medicine and Pharmacy, Institute of Evolution and Marine Biodiversity, College of Food Science and Engineering, Ocean University of China, Qingdao, China have published the article: Identification of marine natural product Pretrichodermamide B as a STAT3 inhibitor for efficient anticancer therapy, in the Journal: (JOURNAL)
- what: This study demonstrated that Pretrichodermamide B is a novel STAT3 inhibitor which should be considered for further exploration as a promising anti-cancer therapy.
- how: In a word these docking results indicated that Pretrichodermamide B may disrupt the formation of STAT3 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.